A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE

被引：9
|
作者：
Smith, R. [1 ]
Jayne, D. [2 ]
Merkel, P. A. [3 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Univ Cambridge, Cambridge, England
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.2717
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0026
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [1] A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE
    Smith, Rona
    Jayne, David
    Merkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2185 - 2185
  • [2] A Randomized, Controlled Trial of Rituximab versus Azathioprine After Induction of Remission with Rituximab for Patients with ANCA-associated Vasculitis and Relapsing Disease
    Smith, Rona
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Extended Follow-Up of Patients Recruited to a Randomized, Controlled Trial of Rituximab versus Azathioprine After Induction of Remission with Rituximab for Patients with ANCA-Associated Vasculitis and Relapsing Disease
    Smith, Rona
    Jayne, David
    Merkel, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
    Smith, Rona M.
    Jones, Rachel B.
    Specks, Ulrich
    Bond, Simon
    Nodale, Marianna
    Al-jayyousi, Reem
    Andrews, Jacqueline
    Bruchfeld, Annette
    Camilleri, Brian
    Carette, Simon
    Cheung, Chee Kay
    Derebail, Vimal
    Doulton, Tim
    Ferraro, Alastair
    Forbess, Lindsy
    Fujimoto, Shouichi
    Furuta, Shunsuke
    Gewurz-Singer, Ora
    Harper, Lorraine
    Ito-Ihara, Toshiko
    Khalidi, Nader
    Klocke, Rainer
    Koening, Curry
    Komagata, Yoshinori
    Langford, Carol
    Lanyon, Peter
    Luqmani, Raashid
    McAlear, Carol
    Moreland, Larry W.
    Mynard, Kim
    Nachman, Patrick
    Pagnoux, Christian
    Peh, Chen Au
    Pusey, Charles
    Ranganathan, Dwarakanathan
    Rhee, Rennie L.
    Spiera, Robert
    Sreih, Antoine G.
    Tesar, Vladamir
    Walters, Giles
    Wroe, Caroline
    Jayne, David
    Merkel, Peter A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (07) : 937 - 944
  • [5] Rituximab versus azathioprine for ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (05): : e252 - e252
  • [6] Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
    Timlin, H.
    Lee, S. M.
    Manno, R. L.
    Seo, P.
    Geetha, Duvura
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 67 - 69
  • [7] Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
    Guillevin, L.
    Pagnoux, C.
    Karras, A.
    Khouatra, C.
    Aumaitre, O.
    Cohen, P.
    Maurier, F.
    Decaux, O.
    Ninet, J.
    Gobert, P.
    Quemeneur, T.
    Blanchard-Delaunay, C.
    Godmer, P.
    Puechal, X.
    Carron, P. -L.
    Hatron, P. -Y.
    Limal, N.
    Hamidou, M.
    Ducret, M.
    Daugas, E.
    Papo, T.
    Bonnotte, B.
    Mahr, A.
    Ravaud, P.
    Mouthon, L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (19): : 1771 - 1780
  • [8] DETERMINANTS OF RITUXIMAB PHARMACOKINETICS AND REMISSION INDUCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Cornec, Divi
    Kabat, Brian F.
    Mills, John R.
    Cheu, Melissa
    Hummel, Amber M.
    Schroeder, Darrell R.
    Cascino, Matthew D.
    Brunetta, Paul
    Murray, David L.
    Snyder, Melissa R.
    Fervenza, Fernando
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    Clair, E. William St.
    Stone, John H.
    Barnidge, David R.
    Specks, Ulrich
    RHEUMATOLOGY, 2017, 56 : 154 - 154
  • [9] Rituximab versus azathioprine for maintenance therapy in ANCA-associated vasculitis
    Clark, Anna
    LANCET RHEUMATOLOGY, 2020, 2 (01): : E12 - E12
  • [10] Rituximab or Azathioprine Maintenance in ANCA-Associated Vasculitis
    Chouchana, Laurent
    Beaune, Philippe
    Loriot, Marie-Anne
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04): : 386 - 386
12345